Primary |
Drug Use For Unknown Indication |
33.3% |
Meniere's Disease |
33.3% |
Anxiety |
16.7% |
Osteoarthritis |
16.7% |
|
|
Secondary |
Schizophrenia, Paranoid Type |
25.6% |
Drug Use For Unknown Indication |
23.3% |
Essential Hypertension |
9.3% |
Cardiac Failure |
4.7% |
Hypertension |
4.7% |
Osteoporosis |
4.7% |
Psoriatic Arthropathy |
4.7% |
Constipation |
2.3% |
Dizziness |
2.3% |
Dysthymic Disorder |
2.3% |
Gastrooesophageal Reflux Disease |
2.3% |
Hyperlipidaemia |
2.3% |
Hyperuricaemia |
2.3% |
Intestinal Functional Disorder |
2.3% |
Osteoarthritis |
2.3% |
Pain |
2.3% |
Vertigo |
2.3% |
|
Electrocardiogram Qt Prolonged |
32.0% |
Transaminases Increased |
12.0% |
Bundle Branch Block Right |
8.0% |
Diabetic Hyperosmolar Coma |
8.0% |
Skin Odour Abnormal |
8.0% |
Ageusia |
4.0% |
Cardiac Arrest |
4.0% |
Convulsion |
4.0% |
Intentional Drug Misuse |
4.0% |
Orthostatic Hypotension |
4.0% |
Pancreatitis Necrotising |
4.0% |
Renal Failure Acute |
4.0% |
Weight Decreased |
4.0% |
|
Concomitant |
Drug Use For Unknown Indication |
19.0% |
Product Used For Unknown Indication |
18.6% |
Hypertension |
13.3% |
Vertigo |
6.8% |
Pain |
5.1% |
Atrial Fibrillation |
3.8% |
Dizziness |
3.8% |
Rheumatoid Arthritis |
3.8% |
Meniere's Disease |
3.6% |
Osteoporosis |
3.2% |
Induction Of Anaesthesia |
2.5% |
Dysphonia |
2.1% |
Diarrhoea |
1.9% |
Palmar-plantar Erythrodysaesthesia Syndrome |
1.9% |
Prophylaxis |
1.9% |
Renal Cell Carcinoma |
1.9% |
Anxiety |
1.7% |
Cardiac Disorder |
1.7% |
Colorectal Cancer Metastatic |
1.7% |
Diabetes Mellitus |
1.7% |
|
Cerebrovascular Accident |
9.4% |
Vertigo |
9.4% |
Vomiting |
9.4% |
Heart Rate Decreased |
5.9% |
Hypotension |
5.9% |
Thrombocytopenia |
5.9% |
Wheezing |
5.9% |
Acute Myocardial Infarction |
4.7% |
Hodgkin's Disease |
4.7% |
Nausea |
4.7% |
Pain |
4.7% |
Bradycardia |
3.5% |
Hyperthyroidism |
3.5% |
Lymphoedema |
3.5% |
Rash Erythematous |
3.5% |
Renal Failure |
3.5% |
Somnolence |
3.5% |
Tremor |
3.5% |
Anaphylactic Shock |
2.4% |
Anxiety |
2.4% |
|